Trimethobenzamide HCl, 250 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
Aetna
| Facility | $0.30 | $0.30 | $0.63 | |
Aetna
| Professional | $0.28 | $0.28 | $0.30 | |
BCBS
| Facility | $0.84 | $0.90 | $1.08 | |
BCBS
| Professional | $0.83 | $0.84 | $0.95 | |
Cigna
| Facility | $0.84 | $0.84 | $0.84 | |
Cigna
| Professional | $0.84 | $0.84 | $0.84 | |
United
| Professional | $0.84 | $0.84 | $0.88 |
Want provider-level rates data? We offer custom data extracts for a reasonable fee. To learn more, please email us.